Target intelligence / Profile preview

Chytridiomycota

Molecular classification
Other (Fungal phylum)
01

Overview

Chytridiomycota is a **phylum of fungi** characterized by producing motile zoospores with a single posterior whiplash flagellum. Members are commonly known as chytrids and are among the most primitive true fungi. They are primarily found in aquatic environments or moist soils and play essential roles as decomposers (saprobes), breaking down refractory materials like chitin and keratin, thus contributing to nutrient cycling[1][5][9]. Some species act as parasites on algae, plants, insects, or amphibians; for example, *Batrachochytrium dendrobatidis* is responsible for chytridiomycosis—a disease implicated in global amphibian population declines[1][5][9]. Chytrids can be unicellular or form simple multicellular structures without septa between cells. Their evolutionary significance lies in their position as one of the earliest diverging fungal lineages[2]. **Note:** "Chytridiomycota fungus" refers to an entire fungal phylum rather than a specific molecular target such as a receptor or enzyme. Therefore, it is not considered a therapeutic target but rather an organismal group containing many different potential targets within its member species. If you seek information about druggable targets related to diseases caused by chytrid fungi (e.g., proteins from *Batrachochytrium dendrobatidis*), please specify the particular molecule or protein of interest[1][2][5].

Other names
chytridsChytridiomycetes (class within the phylum)
02

Biological functions

Decomposition of organic matterNutrient cyclingParasitism of plants, algae, and animals
03

Disease associations

Infection (notably chytridiomycosis in amphibians)
04

Safety considerations

Environmental impact due to pathogenic species causing amphibian declines

Beyond the preview

Go deeper on Chytridiomycota.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chytridiomycota.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call